TSOI
Therapeutic Solutions International, Inc.
Set alert
0.00 USD 0.00 -90.00%
0.0001 Day range 0.0001
0.00001 52-week range 0.0001
- YTD
- -90.00%
- 1 year
- -90.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 51.23K
- Vol
- 262.50K
- Avg vol
- 4.26K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
News
- Therapeutic Solutions International to Voluntarily Delist
- Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases
- Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
- Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product
- Therapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell Differentiation
- Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities
- Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™
- Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease
- Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression
- Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA
Your note
Sign in to keep a note on TSOI — it syncs with the Stock Master app.